Muscarinic receptor agonists stimulate matrix metalloproteinase 1-dependent invasion of human colon cancer cells.
Mammalian matrix metalloproteinases (MMPs) which degrade extracellular matrix facilitate colon cancer cell invasion into the bloodstream and extra-colonic tissues; in particular, MMP1 expression correlates strongly with advanced colon cancer stage, hematogenous metastasis and poor prognosis. Likewise, muscarinic receptor signaling plays an important role in colon cancer; muscarinic receptors are over-expressed in colon cancer compared to normal colon epithelial cells. Muscarinic receptor activation stimulates proliferation, migration and invasion of human colon cancer cells. In mouse intestinal neoplasia models genetic ablation of muscarinic receptors attenuates carcinogenesis. In the present work, we sought to link these observations by showing that MMP1 expression and activation plays a mechanistic role in muscarinic receptor agonist-induced colon cancer cell invasion. We show that acetylcholine, which robustly increases MMP1 expression, stimulates invasion of HT29 and H508 human colon cancer cells into human umbilical vein endothelial cell monolayers - this was abolished by pre-incubation with atropine, a non-selective muscarinic receptor inhibitor, and by pre-incubation with anti-MMP1 neutralizing antibody. Similar results were obtained using a Matrigel chamber assay and deoxycholyltaurine (DCT), an amidated dihydroxy bile acid associated with colon neoplasia in animal models and humans, and previously shown to interact functionally with muscarinic receptors. DCT treatment of human colon cancer cells resulted in time-dependent, 10-fold increased MMP1 expression, and DCT-induced cell invasion was also blocked by pre-treatment with anti-MMP1 antibody. This study contributes to understanding mechanisms underlying muscarinic receptor agonist-induced promotion of colon cancer and, more importantly, indicates that blocking MMP1 expression and activation has therapeutic promise to stop or retard colon cancer invasion and dissemination.
Division of Gastroenterology & Hepatology, University of Maryland School of Medicine, Baltimore, MD 21201, USA. jraufman@medicine.umaryland.edu
Jean-Pierre
JP
Raufman
Kunrong
K
Cheng
Neeraj
N
Saxena
Ahmed
A
Chahdi
Angelica
A
Belo
Sandeep
S
Khurana
Guofeng
G
Xie
D000109:Acetylcholine / Q000378:metabolism / Q000494:pharmacology; D002465:Cell Movement / Q000187:drug effects; D003110:Colonic Neoplasms / Q000201:enzymology / Q000473:pathology*; D019073:HT29 Cells; D006801:Humans; D020781:Matrix Metalloproteinase 1 / Q000235:genetics / Q000378:metabolism*; D018721:Muscarinic Agonists / Q000494:pharmacology*; D009361:Neoplasm Invasiveness; D011976:Receptors, Muscarinic / Q000378:metabolism*; D013657:Taurodeoxycholic Acid / Q000494:pharmacology
D018721:Muscarinic Agonists; D011976:Receptors, Muscarinic; D013657:Taurodeoxycholic Acid; C522360:MMP1 protein, human; D020781:Matrix Metalloproteinase 1; D000109:Acetylcholine